Daar S - Search Results

1

Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.

Pathare A, Taher A, Daar S. Pathare A, et al. Among authors: daar s. Ann Hematol. 2010 Apr;89(4):405-9. doi: 10.1007/s00277-009-0838-z. Epub 2009 Oct 2. Ann Hematol. 2010. PMID: 19798501 Free PMC article. Clinical Trial.

2

Cytokines in sickle cell disease.

Pathare A, Kindi SA, Daar S, Dennison D. Pathare A, et al. Among authors: daar s. Hematology. 2003 Oct;8(5):329-37. doi: 10.1080/10245330310001604719. Hematology. 2003. PMID: 14530175 Review.

3

Cytokine profile of sickle cell disease in Oman.

Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D. Pathare A, et al. Among authors: daar s. Am J Hematol. 2004 Dec;77(4):323-8. doi: 10.1002/ajh.20196. Am J Hematol. 2004. PMID: 15551290 Free article.

4

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.

Daar S, Pathare AV. Daar S, et al. Ann Hematol. 2006 May;85(5):315-9. doi: 10.1007/s00277-005-0075-z. Epub 2006 Feb 1. Ann Hematol. 2006. PMID: 16450126 Clinical Trial.

5

Haematological and clinical features of beta-thalassaemia associated with Hb Dhofar.

Daar S, Gravell D, Hussein HM, Pathare AV, Wali Y, Krishnamoorthy R. Daar S, et al. Eur J Haematol. 2008 Jan;80(1):67-70. doi: 10.1111/j.1600-0609.2007.00989.x. Eur J Haematol. 2008. PMID: 18173741

6

Hematopoietic stem cell transplantation in Oman.

Dennison D, Al Kindi S, Pathare A, Daar S, Nusrat N, Ur Rehman J, Zia F, Khan H, Khan MI, Alghazaly A, Al Zadjali S, Tauro M, Al Lawatia A, Ganguly S. Dennison D, et al. Among authors: daar s. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S109-S113. doi: 10.1038/bmt.2008.131. Bone Marrow Transplant. 2008. PMID: 18724280

7

T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman.

Daar S, Pathare AV, Jain R, Zadjali SA, Pennell DJ. Daar S, et al. Haematologica. 2009 Jan;94(1):140-1. doi: 10.3324/haematol.13845. Epub 2008 Nov 10. Haematologica. 2009. PMID: 19001285 Free PMC article. No abstract available.

8

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study.

Taher A, El-Beshlawy A, Elalfy MS, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri A. Taher A, et al. Among authors: daar s. Eur J Haematol. 2009 Jun;82(6):458-65. doi: 10.1111/j.1600-0609.2009.01228.x. Epub 2009 Jan 28. Eur J Haematol. 2009. PMID: 19187278 Free PMC article. Clinical Trial.

9

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia.

Daar S, Pathare A, Nick H, Kriemler-Krahn U, Hmissi A, Habr D, Taher A. Daar S, et al. Eur J Haematol. 2009 Jun;82(6):454-7. doi: 10.1111/j.1600-0609.2008.01204.x. Epub 2008 Dec 22. Eur J Haematol. 2009. PMID: 19191863 Free PMC article. Clinical Trial.

10

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD. Taher AT, et al. Among authors: daar s. Blood. 2010 Mar 11;115(10):1886-92. doi: 10.1182/blood-2009-09-243154. Epub 2009 Dec 23. Blood. 2010. PMID: 20032507 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page